Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Alexion Pharmaceutical Inc. buy melinda

Start price
€132.65
15.09.17
Target price
€175.89
Performance (%)
-18.990%
End price
€107.46
26.12.17

Comments by melinda for this prediction

In the thread Alexion Pharmaceutical Inc. diskutieren

Published 15.09.17
Prediction Buy
Perf. (%) -18.990%
Target price 175.890
Change

Pharma SecteurProduits



Alexion fügt Paul A. Friedman, MD in den Vorstand

- Der ehemalige Präsident und CEO von Incyte bringt umfangreiche Erfahrung in F & E und Biotechnologie -



Published 26.12.17
Prediction Buy
Perf. (%) -18.990%
Target price 175.890
Change

(Vom Mitglied beendet)

Current prediction by melinda for Alexion Pharmaceutical Inc.

buy

Start price
Target price
Perf. (%)
€70.50
€95.00
23.163%

Stopped prediction by melinda for Alexion Pharmaceutical Inc.

Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€125.50
€130.79
-43.827%

Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€112.84
€153.34
-6.260%